Sayre Therapeutics' Debt Round

Sayre Therapeutics raised a round of funding on September 05, 2017. Investors include InnoVen Capital.

Sayre Therapeutics is a super-specialty pharma company which has a portfolio of oncology, interventional oncology and immunology drugs, drug delivery devices and diagnostics.…

Articles about Sayre Therapeutics' Debt Round: